Überprüfung…
Automatisch übersetzt. Dosierung und Warnhinweise: bitte im englischen Original prüfen. Auf Englisch lesen

Venlafaxine

Venlafaxine is a brand of Venlafaxine.

Venlafaxine tablets, USP are indicated for the treatment of major depressive disorder. The efficacy of venlafaxine tablets, USP in the treatment of ma.

Checked against the official label · Updated

Prescription medicine Oral Safety alerts on record

Venlafaxine: quick answers

Used for
Venlafaxine tablets, USP are indicated for the treatment of major depressive disorder.
Children
With food?
Initial Treatment The recommended starting dose for venlafaxine tablets is 75 mg/day, administered in two or three divided doses, taken with food.
Prescription
Prescription medicine in the United States; rules differ by country.

From the official label (Feb 2025). Your prescription and pharmacist come first.

How to use Venlafaxine

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Serious warning: Suicidality and Antidepressant Drugs Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of venlafaxine tablets or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. …
Who it is for

Venlafaxine tablets, USP are indicated for the treatment of major depressive disorder. The efficacy of venlafaxine tablets, USP in the treatment of major depressive disorder was established in 6 week controlled trials of adult outpatients whose diagnoses corresponded most closely to the DSM-III or DSM-III-R category of major depression and in a 4 week controlled trial of inpatients meeting diagnostic criteria for major depression with melancholia (see CLINICAL TRIALS ). …

How to take it and how often
  • Initial Treatment The recommended starting dose for venlafaxine tablets is 75 mg/day, administered in two or three divided doses, taken with food
  • Depending on tolerability and the need for further clinical effect, the dose may be increased to 150 mg/day
  • If needed, the dose should be further increased up to 225 mg/day
  • When increasing the dose, increments of up to 75 mg/day should be made at intervals of no less than 4 days
  • In outpatient settings there was no evidence of usefulness of doses greater than 225 mg/day for moderately depressed patients, but more severely depressed inpatients responded to a mean dose of 350 mg/day
  • Certain patients, including more severely depressed patients, may therefore respond more to higher doses, up to a maximum of 375 mg/day, generally in three divided doses (see PRECAUTIONS , General , Use in Patients with Concomitant Illness)
  • Special Populations Treatment of Pregnant Women During the Third Trimester
  • Neonates exposed to venlafaxine tablets, other SNRIs, or SSRIs, late in the third trimester have developed complications requiring prolonged hospitalization, respiratory support, and tube feeding (see PRECAUTIONS )
  • When treating pregnant women with venlafaxine tablets during the third trimester, the physician should carefully consider the potential risks and benefits of treatment. …
Children
  • Safety and effectiveness in the pediatric population have not been established (see BOX WARNING and WARNINGS, Clinical Worsening and Suicide Risk )
  • Two placebo-controlled trials in 766
  • Pediatric patients with MDD and two placebo-controlled trials in 793
  • Pediatric patients with GAD have been conducted with venlafaxine hydrochloride extended-release capsules, and the data were not sufficient to support a claim for use
  • In pediatric patients
  • Anyone considering the use of venlafaxine tablets in a child or adolescent must balance the potential risks with the clinical need. …
Older adults

Of the 2,897 patients in Phase 2 and Phase 3 depression studies with venlafaxine tablets, 12% (357) were 65 years of age or over. No overall differences in effectiveness or safety were observed between these patients and younger patients, and other reported clinical experience generally has not identified differences in response between the elderly and younger patients. However, greater sensitivity of some older individuals cannot be ruled out. …

While you are taking it
  • Prescribers or other health professionals should inform patients, their families, and their caregivers about the benefits and risks associated with treatment with venlafaxine tablets and should counsel them in its appropriate use
  • A patient Medication Guide about "Antidepressant Medicines, Depression and Other Serious Mental Illness, and Suicidal Thoughts or Actions" is available for venlafaxine tablets
  • The prescriber or health professional should instruct patients, their families, and their caregivers to read the Medication Guide and should assist them in understanding its contents. …
Talk to a doctor first if
  • Hypersensitivity to venlafaxine hydrochloride or to any excipients in the formulation
  • The use of MAOIs intended to treat psychiatric disorders with venlafaxine tablets or within 7 days of stopping treatment with venlafaxine tablets is contraindicated because of an increased risk of serotonin syndrome
  • The use of venlafaxine tablets within 14 days of stopping an MAOI intended to treat psychiatric disorders is also contraindicated (see WARNINGS and DOSAGE AND ADMINISTRATION ). …
Medicines it may not mix with

As with all drugs, the potential for interaction by a variety of mechanisms is a possibility. Alcohol A single dose of ethanol (0.5 g/kg) had no effect on the pharmacokinetics of venlafaxine or ODV when venlafaxine was administered at 150 mg/day in 15 healthy male subjects. Additionally, administration of venlafaxine in a stable regimen did not exaggerate the psychomotor and psychometric effects induced by ethanol in these same subjects when they were not receiving venlafaxine. Cimetidine Concomitant administration of cimetidine and venlafaxine in a steady-state study for both drugs resulted in inhibition of first-pass metabolism of venlafaxine in 18 healthy subjects. …

Warnings

Clinical Worsening and Suicide Risk Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications, and this risk may persist until significant remission occurs. Suicide is a known risk of depression and certain other psychiatric disorders, and these disorders themselves are the strongest predictors of suicide. …

Possible side effects

Associated with Discontinuation of Treatment Nineteen percent (537/2897) of venlafaxine patients in Phase 2 and Phase 3 depression studies discontinued treatment due to an adverse event. The more common events (≥ 1%) associated with discontinuation and considered to be drug-related (i.e., those events associated with dropout at a rate approximately twice or greater for venlafaxine compared to placebo) included: CNS Venlafaxine Placebo * Percentages based on the number of males. …

Pregnancy and breastfeeding

Clinical Worsening and Suicide Risk Patients, their families, and their caregivers should be encouraged to be alert to the emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, other unusual changes in behavior, worsening of depression, and suicidal ideation, especially early during antidepressant treatment and when the dose is adjust …

If you take too much

Human Experience There were 14 reports of acute overdose with venlafaxine tablets, either alone or in combination with other drugs and/or alcohol, among the patients included in the premarketing evaluation. The majority of the reports involved ingestions in which the total dose of venlafaxine tablets taken was estimated to be no more than several-fold higher than the usual therapeutic dose. The 3 patients who took the highest doses were estimated to have ingested approximately 6.75 g, 2.75 g, and 2.5 g. …

Dependence and misuse

Controlled Substance Class Venlafaxine tablets are not a controlled substance. Physical and Psychological Dependence In vitro studies revealed that venlafaxine has virtually no affinity for opiate, benzodiazepine, phencyclidine (PCP), or N-methyl-D-aspartic acid (NMDA) receptors. Venlafaxine was not found to have any significant CNS stimulant activity in rodents. In primate drug discrimination studies, venlafaxine showed no significant stimulant or depressant abuse liability. …

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2025-02-04.

How much Venlafaxine costs

In other countries

Prices in other countries are not what you will pay where you live; they show how prices compare.

Same medicine, other brands

Products with Venlafaxine as the active ingredient. Names differ between countries.

Registered products

United States (FDA)

O-desmethyl Venlafaxine SuccinateDESVENLAFAXINE SUCCINATE 25 kg/25kg · Powder · Cadila Pharmaceuticals Limited
NDC 65691-0067Label
VenlafaxineVENLAFAXINE HYDROCHLORIDE 37.5 mg/1 · Tablet · REMEDYREPACK INC.
NDC 70518-4779Label
Venlafaxine HydrochlorideVENLAFAXINE HYDROCHLORIDE 75 mg/1 · Capsule, Extended Release · Marlex Pharmaceuticals, Inc.
NDC 10135-826Label
VenlafaxineVENLAFAXINE HYDROCHLORIDE 100 mg/1 · Tablet · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
NDC 23155-250Label
Venlafaxine HydrochlorideVENLAFAXINE HYDROCHLORIDE 75 mg/1 · Capsule, Extended Release · AvKARE
NDC 42291-898Label

Other countries: check your pack's registration number and we point you to your regulator.

Safety alerts and recalls

Venlafaxine Tablets, USP, 75 mg, 100 Tablets, Rx only, Mfg. by: Zydus Lifesciences Ltd, Ahmedabad, India, Dist. by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 6838U.S. FDA Class II
21 Mar 2025 · Zydus Pharmaceuticals (USA) Inc · CompletedPresence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.
Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.U.S. FDA Class III
16 Jan 2025 · Appco Pharma LLC · CompletedFailed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet
Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5mg, packaged in a) 90-count bottles (NDC 68382-034-16) and b)1000-count bottles (NDC 68382-034-10), Rx only, Mfg. by: ZU.S. FDA Class II
21 Jun 2024 · Zydus Pharmaceuticals (USA) Inc · TerminatedFailed Dissolution Specifications: Out-of-specification results observed for dissolution testing at the 8-hour and 12-hour pull intervals.
Venlafaxine Hydrochloride, extended-release capsules, USP, 37.5mg, 10 x 10 blister card in one carton, Rx only, Mfg by: Cadila Healthcare Ltd., Ahmedabad, India, Distributed by: MaU.S. FDA Class II
18 Jun 2024 · The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories · TerminatedFailed dissolution specifications: out of specification result obtained during routine stability testing for high dissolution.

A recall usually affects certain batches only. Compare the lot number on your pack.

Check your pack of Venlafaxine

Type the registration number on the pack, or scan it with your camera.

Or take photos of the pack
3 free checks left today Official sources: U.S. FDA · EMA (EU) · Health Canada · WHO alerts

Questions about Venlafaxine

What is in Venlafaxine?

Venlafaxine contains Venlafaxine. Other brands with the same active ingredient work the same way; the dose and strength on your pack are what matter.

What is Venlafaxine used for?

Venlafaxine tablets, USP are indicated for the treatment of major depressive disorder. The efficacy of venlafaxine tablets, USP in the treatment of major depressive disorder was established in 6 week controlled trials of adult outpatients whose diagnoses corresponded most closely to the DSM-III or DSM-III-R category of major depression and in a 4 week controlled trial of inpatients meeting diagnostic criteria for maj (From the official U.S. FDA label.)

How do I take Venlafaxine?

Follow your prescription or the leaflet in your pack. The official label says: Initial Treatment The recommended starting dose for venlafaxine tablets is 75 mg/day, administered in two or three divided doses, taken with food. Depending on tolerability and the need for further clinical effect, the dose may be increased to 150 mg/day. If needed, the dose should be further increased up to 225 mg/day. When increasing the dose, increments of up to 75 mg/day sh…

Should I take Venlafaxine with food?

Initial Treatment The recommended starting dose for venlafaxine tablets is 75 mg/day, administered in two or three divided doses, taken with food.

Do I need a prescription for Venlafaxine?

Usually yes. Venlafaxine is a prescription medicine in most countries. Rules differ by country.

What brands contain Venlafaxine?

Venlafaxine is sold under names such as Effexor. Brand names differ between countries.

What are the side effects of Venlafaxine?

The official label lists: Associated with Discontinuation of Treatment Nineteen percent (537/2897) of venlafaxine patients in Phase 2 and Phase 3 depression studies discontinued treatment due to an adverse event. The more common events (≥ 1%) associated with discontinuation and considered to be drug-related (i.e., those events associated with dropout at a rate approximately twice or greater for venlafax… Tell your doctor about any side effect that bothers you or does not go away.

Can children take Venlafaxine?

Safety and effectiveness in the pediatric population have not been established (see BOX WARNING and WARNINGS, Clinical Worsening and Suicide Risk ). Two placebo-controlled trials in 766 pediatric patients with MDD and two placebo-controlled trials in 793 pediatric patients with GAD have been conducted with venlafaxine hydrochloride extended-release capsules, and the data were n… Always use the dose for the child's age or weight on the pack or prescription.

Can I take Venlafaxine when pregnant or breastfeeding?

Clinical Worsening and Suicide Risk Patients, their families, and their caregivers should be encouraged to be alert to the emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, other unusual changes in behavior, worsening of depression, and suicidal ideation, especi… Ask your doctor or midwife first.

What medicines interact with Venlafaxine?

As with all drugs, the potential for interaction by a variety of mechanisms is a possibility. Alcohol A single dose of ethanol (0.5 g/kg) had no effect on the pharmacokinetics of venlafaxine or ODV when venlafaxine was administered at 150 mg/day in 15 healthy male subjects. Additionally, administration of venlafaxine in a stable regimen did not exaggerate the psychomotor and ps… Use the free interaction checker before combining medicines.

What happens if I take too much Venlafaxine?

Human Experience There were 14 reports of acute overdose with venlafaxine tablets, either alone or in combination with other drugs and/or alcohol, among the patients included in the premarketing evaluation. The majority of the reports involved ingestions in which the total dose of venlafaxine tablet… Get medical help right away.

How can I check that my Venlafaxine is genuine?

Scan the registration number on your pack with PillVera (NAFDAC number in Nigeria, NDC in the United States, DIN in Canada), check the expiry date and buy only from licensed pharmacies.

Sources

This page shows what official sources say, in plain words. It is not medical advice: your prescription and your doctor or pharmacist come first. Brand names, strengths and rules differ between countries.